Business update – Essential Business
26 March 2020
Business update – Essential Business
Brian Watson, Chief Executive Officer of Blis Technologies (NZX:BLT), has confirmed Blis
Technologies will remain operational following the Government overnight raising the national
COVID-19 response to Level 4. Blis Technologies manufacturing and elements of its scientific services
are classified as “essential services”. The company has completed the MPI registration process to
maintain that status, and subject to that, they will continue operating.
As manufacturers of unique probiotics that support immunity, Blis Technologies is an important
supplier to consumers in NZ through pharmacies and online sales. Essential functions at Blis
Technologies will remain operational during the COVID-19 Level 4 period to ensure BLIS Probiotics
can continue to be supplied to support immunity and throat health of thousands of New Zealanders
during a time of high need and into the winter cold and flu season.
Blis Technologies is committed to delivering services in accordance with the Government’s guidance
to protect the health and wellbeing of all New Zealanders. Staff that do not have a critical role in
manufacture or testing are working from home. Workplace segregation, social distancing and
sanitisation protocols are fully implemented at both our sites.
We are working closely with our suppliers to ensure continuity of supply.
Ends
For further information, please contact:
Brian Watson
CEO
+64 27 705 9133
About Blis Technologies Ltd
Delivering proven health benefits through evidence-based, advanced probiotics
Blis is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation
with evidence-based research and the highest quality production controls enables the delivery of probiotic
solutions for specific health targets including throat health, halitosis (bad breath), immune support and teeth and
gum health. BLIS products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More
information about Blis Technologies Ltd can be found at www.blis.co.nz.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- PEB — Pacific Edge Limited: PEB TO CONTINUE PROVIDING ESSENTIAL DIAGNOSTIC SERVICES2020-03-24
“Company Announcement 25 March 2020 PEB TO CONTINUE PROVIDING ESSENTIAL DIAGNOSTIC SERVICES Pacific Edge will continue to provide essential cancer diagnostic services during COVID-19 shutdown in both New Zealand and USA Cancer diagnostic company, Pacific Edge, advi…”
- THL — Tourism Holdings Limited: General market update2020-04-03
“Tourism Holdings Limited Tel: +64 9 336 4299 The Beach House Fax: +64 9 309 9269 Level 1, 83 Beach Road www.thlonline.com Auckland City PO Box 4293, Shortland Street Auckland 1140, New Zealand Self drive Experiences New Zealand Australia USA UK Desig…”
- NZX — NZX Limited: NZX fully operational – update COVID-19 – 23 March 20202020-03-22
“NZX fully operational – markets, regulatory function and services 23 March 2020 – Following the Government’s announcement on 21 March 2020 outlining the New Zealand COVID-19 Alert Levels, NZX confirms that the capital markets – as an essential service to New Zealand – will rem…”